FDA-Drug2023-08-30Class II

Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004

Hazard

CGMP Deviations

Sold states
Nationwide within the United States, Singapore, Korea and Hong Kong
Affected count
40
Manufactured in
286 Eldridge Rd, N/A, Fairfield, NJ, United States
Products
Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1092-2023

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief